Sign In
Buy LH
$309.20
-6.33 (-2.01%)
At Close: Jul 31, 2026
Labcorp Expands Sexually Transmitted Infection (STI) Test Offerings with Rapid Syphilis Test
08:30am, Thursday, 10'th Oct 2024
Labcorp to serve as the exclusive NOWDiagnostics (NOWDx) distributor for clinical testing in the U.S., offering First to Know® Syphilis Test nationwide BURLINGTON, N.C. , Oct 10, 2024 /PRNewswire/ --
Labcorp Declares Quarterly Dividend
06:50am, Thursday, 10'th Oct 2024
BURLINGTON, N.C. , Oct. 10, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a ca
Labcorp Stock Gains From Biopharma Business Amid FX Woe
01:50pm, Monday, 07'th Oct 2024
LH is well-placed for long-term success in Cell & Gene Therapy, expanding into the consumer market and international growth through the specialty testing and biopharma business.
Should You Continue to Retain LH Stock in Your Portfolio?
09:26am, Wednesday, 25'th Sep 2024
Labcorp's expanding testing solutions in high-growth areas, partnerships and focus on operational efficiency instill optimism.
Labcorp to Announce Third Quarter Financial Results on October 24, 2024
04:16pm, Tuesday, 24'th Sep 2024
BURLINGTON, N.C. , Sept. 24, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the third quarter of
LH Stock Likely to Gain From the Molecular Bioanalytical Lab Expansion
10:10am, Tuesday, 24'th Sep 2024
Labcorp expands the molecular bioanalytical laboratory in Greenfield, IN.
Ovia Health Expands Women's Health Offerings with Comprehensive Postpartum Experience
07:00am, Wednesday, 18'th Sep 2024
New solution is the first holistic program available in a digital app to help women manage the postpartum period BOSTON , Sept. 18, 2024 /PRNewswire/ -- Ovia Health by Labcorp (Ovia) today announced t
Labcorp Stock Gains From Its Latest Acquisition of BioReference Health
01:15pm, Tuesday, 17'th Sep 2024
LH completes the acquisition of BioReference Health, a wholly-owned subsidiary of OPKO Health. The acquisition includes BioReference Health's laboratory testing businesses.
BURLINGTON, N.C. , Sept. 16, 2024 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE:LH) (Labcorp) announced today that its wholly owned subsidiary, Laboratory Corporation of America Holdings (LCAH), has pri
Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health
07:30am, Monday, 16'th Sep 2024
Enhances Labcorp's laboratory services network and expands access to its clinical services BURLINGTON, N.C. and MIAMI , Sept.
Labcorp Stock Gains From Market Expansion Efforts Amid Macro Woes
12:01pm, Thursday, 12'th Sep 2024
LH is well-placed for long-term success in Cell & Gene Therapy, expanding into the consumer market and international growth through the specialty testing and biopharma business.
LH Stock Expected to Gain From the Ballad Health Acquisition Deal
09:27am, Wednesday, 11'th Sep 2024
Labcorp has reached an agreement to purchase select outreach laboratory services from Ballad Health.
Labcorp to Speak at the Baird 2024 Global Healthcare Conference
04:09pm, Tuesday, 03'rd Sep 2024
BURLINGTON, N.C. , Sept. 3, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that members of the executive management tea
Labcorp says it could ramp up mpox testing capacity
06:22am, Monday, 26'th Aug 2024
Diagnostics firm Labcorp said it is processing approximately 500 mpox tests a month but have the capacity to process approximately 25,000 per month.
Should You Hold Labcorp (LH) Stock in Your Portfolio Now?
09:55am, Thursday, 22'nd Aug 2024
Labcorp's (LH) slew of partnerships and acquisitions and robust efforts in high-growth areas bode well.
